These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Short-term in vivo inhibition of insulin receptor substrate-1 expression leads to insulin resistance, hyperinsulinemia, and increased adiposity. Araújo EP; De Souza CT; Gasparetti AL; Ueno M; Boschero AC; Saad MJ; Velloso LA Endocrinology; 2005 Mar; 146(3):1428-37. PubMed ID: 15550510 [TBL] [Abstract][Full Text] [Related]
23. GTK tyrosine kinase-induced alteration of IRS-protein signalling in insulin producing cells. Annerén C; Welsh M Mol Med; 2002 Nov; 8(11):705-13. PubMed ID: 12520087 [TBL] [Abstract][Full Text] [Related]
24. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells. Hennige AM; Ozcan U; Okada T; Jhala US; Schubert M; White MF; Kulkarni RN Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066 [TBL] [Abstract][Full Text] [Related]
25. Postnatal growth responses to insulin-like growth factor I in insulin receptor substrate-1-deficient mice. Pete G; Fuller CR; Oldham JM; Smith DR; D'Ercole AJ; Kahn CR; Lund PK Endocrinology; 1999 Dec; 140(12):5478-87. PubMed ID: 10579310 [TBL] [Abstract][Full Text] [Related]
26. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851 [TBL] [Abstract][Full Text] [Related]
27. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Ueki K; Kondo T; Kahn CR Mol Cell Biol; 2004 Jun; 24(12):5434-46. PubMed ID: 15169905 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of p53 Relieves Insulin Resistance in Fetal Growth Restriction Mice with Catch-Up Growth via Activating IGFBP3/IGF-1/IRS-1/Akt Signaling Pathway. Peng P; Ma C; Wan S; Jin W; Gao Y; Huang T; Cheng Q; Ye C J Nanosci Nanotechnol; 2018 Jun; 18(6):3925-3935. PubMed ID: 29442728 [TBL] [Abstract][Full Text] [Related]
29. Deficiency of insulin receptor substrate-1 impairs skeletal growth through early closure of epiphyseal cartilage. Hoshi K; Ogata N; Shimoaka T; Terauchi Y; Kadowaki T; Kenmotsu S; Chung UI; Ozawa H; Nakamura K; Kawaguchi H J Bone Miner Res; 2004 Feb; 19(2):214-23. PubMed ID: 14969391 [TBL] [Abstract][Full Text] [Related]
30. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328 [TBL] [Abstract][Full Text] [Related]
31. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Fasshauer M; Klein J; Kriauciunas KM; Ueki K; Benito M; Kahn CR Mol Cell Biol; 2001 Jan; 21(1):319-29. PubMed ID: 11113206 [TBL] [Abstract][Full Text] [Related]
33. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Kim B; Leventhal PS; White MF; Feldman EL Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424 [TBL] [Abstract][Full Text] [Related]
34. Insulin receptor substrate-1 is expressed at high levels in all cells of the peri-implantation mouse embryo. Puscheck EE; Pergament E; Patel Y; Dreschler J; Rappolee DA Mol Reprod Dev; 1998 Apr; 49(4):386-93. PubMed ID: 9508089 [TBL] [Abstract][Full Text] [Related]
35. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436 [TBL] [Abstract][Full Text] [Related]
37. Acetylation of insulin receptor substrate-1 is permissive for tyrosine phosphorylation. Kaiser C; James SR BMC Biol; 2004 Nov; 2():23. PubMed ID: 15522123 [TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration. Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456 [TBL] [Abstract][Full Text] [Related]
39. Targeted gene mutations define the roles of insulin and IGF-I receptors in mouse embryonic development. Accili D; Nakae J; Kim JJ; Park BC; Rother KI J Pediatr Endocrinol Metab; 1999; 12(4):475-85. PubMed ID: 10417963 [TBL] [Abstract][Full Text] [Related]
40. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins. Dews M; Nishimoto I; Baserga R Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]